Neuren's Wholly Owned Pipeline
Click on each indication to learn more
| Indication | Compound | Geography | Preclinical / Phase 1 | Phase 2 | Phase 3 | Registration |
|---|---|---|---|---|---|---|
| Phelan-McDermid | NNZ-2591 | World | ||||
| Pitt Hopkins | NNZ-2591 | World | ||||
| HIE | NNZ-2591 | World | ||||
| Angelman | NNZ-2591 | World | ||||
| Prader-Willi | NNZ-2591 | World | ||||
| SYNGAP1 | NNZ-2591 | World |
Licensed to Acadia Pharmaceuticals
Click on each indication to learn more
| Indication | Compound | Geography | Preclinical / Phase 1 | Phase 2 | Phase 3 | Registration |
|---|---|---|---|---|---|---|
| Rett | Trofinetide | US, Canada, Israel, EU | ||||
| RoW | ||||||
| NNZ-2591 | World | |||||
| Fragile X | Trofinetide | World | ||||
| NNZ-2591 | World |